Exploring genetic determinants of antimicrobial resistance in strains of human and animal origin from India.

Introduction: Antimicrobial resistance (AMR) in , the causative agent of brucellosis, is of growing concern, particularly in low and middle-income countries. This study aimed to explore the genetic basis of AMR in strains from India.

Methods: Twenty-four isolates from humans and animals were subjected to antimicrobial susceptibility testing and whole-genome sequencing.

Draft genome sequences of from human and animal sources in India.

We present the draft genome sequences of 23 isolates derived from human and animal sources across India with genome size predominantly at 3.207 M and uniform GC content (57.24%) across isolates.

Waste to energy: A review of biochar production with emphasis on mathematical modelling and its applications.

United Nations charter to build a sustainable future has paved the way for the introduction of the Sustainability Development Goals (SDGs) at a global forum. In particular, SDG 11 is aligned with the idea of developing cities and communities that provide quality human life, by attaining net-zero discharge and self-sustainability. In line with the efforts of the global community, biochar has emerged as a viable solution due to its ability to convert waste into value.

Out-of-pocket spending on hypertension and diabetes among patients reporting in a health -care teaching institute of the Western Rajasthan.

Background: Across the globe, morbidity and mortality due to non-communicable diseases (NCDs) are major public health issues. The resulting concern is not just epidemiological but also about the economic consequences at the household level.

Objective: To assess the various facets of out-of-pocket spending (OOPs) incurring on NCDs, namely hypertension and diabetes on patients attending a healthcare teaching institute in Rajasthan.

Producing personalized statin treatment plans to optimize clinical outcomes using big data and machine learning.

Almost half of Americans 65 years of age and older take statins, which are highly effective in lowering low-density lipoprotein cholesterol, preventing atherosclerotic cardiovascular disease (ASCVD), and reducing all-cause mortality. Unfortunately, ∼50% of patients prescribed statins do not obtain these critical benefits because they discontinue use within one year of treatment initiation. Therefore, statin discontinuation has been identified as a major public health concern due to the increased morbidity, mortality, and healthcare costs associated with ASCVD.